leisure time -WSS

leisure time

author：entertainment 2025-10-01 21:35:56 - browse：45

1:56Threshold Glass Jar Candles sold exclusively by Target.U.S. Consumer Product Safety Commission

Target has recalled another 2.2 million of its Threshold candles due to reports of candle jars breaking or cracking during use.

In May, the United States Consumer Product Safety Commission announced the recall of nearly 5 million Target Threshold candle products after the retailer received 137 reports of it breaking or cracking during use.

Now, the Minnesota-based retailer has recalled another 2.2 million candles, the CPC announced Thursday.

"Target received 19 reports of the candle jar breaking or cracking during use, resulting in one minor injury," the agency stated.

MORE: General Motors recalls over 600K cars due to car seat safety issue

Six injuries were reported in the previous recall, including lacerations and severe burns, according to the CPSC.

"This recall involves certain Threshold Glass Jar 5.5 ounce 1-Wick, 14 ounce 3-Wick and 20 ounce 3-Wick Candles in multiple scents," the CPSC stated. "The recalled item numbers are printed on the bottom of the glass jars."

PHOTO: Threshold Glass Jar Candles sold exclusively by Target. — Threshold Glass Jar Candles sold exclusively by Target.U.S. Consumer Product Safety Commission

Click here for a full list of the recalled product details and item numbers.

The CPSC urged consumers to stop using the recalled candles immediately and return them to Target for a refund. Customers can also contact Target for a prepaid return label to send them back by mail.

The candles, which were manufactured in Vietnam, were sold at Target stores nationwide as well as online from August 2019 through March 2023 for between $3 and $20.

An earlier version of this story was originally published May 19, 2023.

Previous article： In Memoriam: Notable people who died in 2023
Next article： An inside look at PIPEs, biotech's buzzy new financing tool

hotspot

WSS

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

An inside look at PIPEs, biotech's buzzy new financing tool

Flu vaccine offering decent levels of protection this winter, new data show

How a Boston hospital is priming medical residents to use GPT

Why getting cancer drugs just got harder for rural patients

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

explore

leisure time

MORE: General Motors recalls over 600K cars due to car seat safety issue

focus

Affirmative action in medical school literally saved lives

House looks to weaken Medicare negotiation

Novavax promises a turnaround & Lilly roils the obesity market

There’s a way to spot data fakery. All journals should be using it

Virginia high school admissions case could be legal follow

Why getting cancer drugs just got harder for rural patients

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Medicare details structure of new drug price negotiation program

Why getting cancer drugs just got harder for rural patients

focus

How to address the problem of discarded donor organs

How a Boston hospital is priming medical residents to use GPT

FDA does about

Caribou posts encouraging results on off

In search for therapies for solid tumors, companies turn to claudin

RaDonda Vaught to speak at CommonSpirit event on patient safety

hotspot

hotspot

hotspot

focus